HOME >> BIOLOGY >> NEWS
Most Americans open to pharmacogenomics research

DENVER, Colo. -- Most people are open to the idea of using genetics to improve drug therapies, but they don't fully grasp how it works or how it might affect them.

That's the finding of a national survey aimed at assessing public attitudes toward pharmacogenomics, an area of research aimed at discovering the role genes play in how someone will respond to a certain drug.

The survey, funded through a $900,000 National Institutes of Health grant, was conducted by Mark Rothstein, a medical ethics specialist who directs the University of Louisville's Institute for Bioethics, Health Policy and Law. Results of the survey were released at the American Association for the Advancement of Science annual meeting in Denver.

"A lot of public and private research has been devoted to pharmacogenomics in the past several years, but far less attention has been paid to its ethical, legal and social implications," Rothstein said.

One survey goal was to determine whether the average person understands, even in a basic way, the underlying science of pharmacogenomics, he said. The survey found that attitudes varied significantly by educational level, race, income and age, although not by gender.

Nearly eight out of 10 respondents said they were somewhat likely or very likely to take part in genetic research. Whites and Asians were about 8 percent to 10 percent more likely to take part in research than African Americans and Hispanics, and respondents with more education were more willing to take part than those with less education.

By a wide margin, respondents were most likely to trust medical institutions and health organizations to perform the research than the federal government or pharmaceutical companies, the survey found. Asians and Hispanics expressed more trust in the federal government than whites or African Americans.

Income level factored into whether people felt they could afford pharmacogenomic-based drugs. Fewer than ha
'"/>

Contact: Denise Fitzpatrick
denise.fitzpatrick@louisville.edu
502-852-6171
University of Louisville
14-Feb-2003


Page: 1 2

Related biology news :

1. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
2. Most Americans not sure about the sources of high cholesterol
3. Genetic testing of embryos to pick savior sibling OK with most Americans
4. Colorectal cancer rates in African Americans equal with insurance parity
5. Americans speak out on cancer
6. Whites, African-Americans better rate medical care experiences when seeing same-race physicians
7. Does a new hypothesis help explain higher levels of hypertension among African-Americans?
8. Experts to demonstrate latest, cost-cutting computer-based caregiving for older Americans
9. Americans knowledge of genetically modified foods remains low and opinions on safety still split
10. U-M researchers seek answers for African-Americans at risk for prostate cancer
11. African Americans concern about the environment equal to or greater that of whites

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/2/2020)... ... March 02, 2020 , ... Nominations are now being ... by the Security Industry Association (SIA) and SecureIDNews and co-presented ... in Security Forum . The recipients of this year’s Women in Biometrics Awards will ...
(Date:2/28/2020)... ... February 26, 2020 , ... ... its patent-pending Rebound PRP™ and Rebound PRF® devices are now available to ... generation of regenerative medical devices, that will provide the most affordable, easiest ...
(Date:2/28/2020)... , ... February 27, 2020 ... ... (VIC), has formed Filtravate, its newest portfolio company. Established to develop and ... technology exclusively licensed from New Mexico State University (NMSU). The patent-pending technology ...
Breaking Biology News(10 mins):
(Date:3/27/2020)... ... ... iFirst Medical Technologies, Inc., a leader in handheld diagnostic devices, announced today that ... grave danger to public health here in the U.S. and around the globe," said ... and on-the-spot results promise to slow the spread and save human lives." , iFirst ...
(Date:3/13/2020)... ... March 12, 2020 , ... Today, DuPont Nutrition & ... Center (APC), a pioneer in the field of microbiome science, which focuses on ... in human health, based at University College Cork and Teagasc Moorepark. , Representatives ...
(Date:3/10/2020)... ... March 10, 2020 , ... ... chain biopharmaceutical engineering firm, is pleased to announce the addition of Carson ... medical device qualification and validation in the biopharmaceutical cold chain. He provides ...
(Date:3/4/2020)... WASHINGTON (PRWEB) , ... March 04, 2020 , ... This ... Exhibition in Orlando, FL. The company will showcase both expanded and emerging offerings that ... HIMSS 2020 is designed to be comprehensive, timely, and engaging. From ...
Breaking Biology Technology:
Cached News: